Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nawarat Thonwirak"'
Autor:
Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich, Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Mass vaccination with a safe and effective vaccine may be the best way to control the COVID-19 pandemic. Heterologous prime-boost vaccination with the CoronaVac and AZD1222 vaccines may increase the immunogenicity elicited by either vaccine alone. Th
Externí odkaz:
https://doaj.org/article/ace75072a2284f9c82835fe675893969
Autor:
Saraiorn Thonginnetra, Kriangkrai Tawinprai, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Pisuttikan Rangkakulnuwat, Preeda Vanichsetakul, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Nithi Mahanonda
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1765 (2022)
Coronavirus disease 2019 affected child health and impacted learning because of the resulting onsite school closures. This prospective cohort study included children aged 10–17 who received two 4 µg doses of BBIBP-CorV administered intramuscularly
Externí odkaz:
https://doaj.org/article/44c1de25d69f49a59a567ba112fa1cae
Autor:
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Preeda Vanichsetakul, Saraiorn Thonginnetra, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Nithi Mahanonda
Publikováno v:
Vaccines, Vol 10, Iss 5, p 807 (2022)
Adolescents can develop a severe form of Coronavirus disease 2019 (COVID-19), especially with underlying comorbidities. No study has examined the efficacy or effectiveness of inactivated COVID-19 vaccines in adolescents. This single-center, prospecti
Externí odkaz:
https://doaj.org/article/f0920593e03b44738a226c8837f086c0
Autor:
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda
Publikováno v:
Expert review of vaccines. 21(12)
Immunogenicity after the CoronaVac vaccine remains uncertain, especially regarding infections with the coronavirus variants of concern and waning immunity.This was a single-center, open-label clinical trial designed to assess the immunogenicity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fc31996ebc53857dc98b8b35f4386f
https://pubmed.ncbi.nlm.nih.gov/35792752
https://pubmed.ncbi.nlm.nih.gov/35792752
Autor:
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Preeda Vanichsetakul, Saraiorn Thonginnetra, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Nithi Mahanonda
IntroductionCOVID-19 pandemic affects all populations worldwide, including adolescents. Adolescents can develop a severe form of COVID-19, especially with comorbidity underlying. The prior studies of the mRNA COVID-19 vaccine showed excellent effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06391b40840f40d0ea6938d73fe3011b
https://doi.org/10.1101/2022.01.07.22268883
https://doi.org/10.1101/2022.01.07.22268883
Autor:
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda
Publikováno v:
Vaccine. 40(12)
The CoronaVac vaccine is widely used in Thailand to combat the coronavirus disease 2019 (COVID-19) pandemic. The limited immunogenicity of this vaccine is a concern, especially because of expanding delta variant outbreaks. A third boost may enhance a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405c92d8da8a291941bcce06e77f9e12
https://pubmed.ncbi.nlm.nih.gov/35210118
https://pubmed.ncbi.nlm.nih.gov/35210118